1. Epilepsy with eyelid myoclonia (Jeavons syndrome): Generalized, focal, or combined generalized and focal epilepsy syndrome?
- Author
-
Gélisse P, Gallegos C, Nilo A, Macorig G, Genton P, and Crespel A
- Subjects
- Humans, Male, Child, Preschool, Female, Child, Myoclonus physiopathology, Myoclonus diagnosis, Eyelids physiopathology, Electroencephalography, Epilepsies, Partial physiopathology, Epilepsies, Partial diagnosis, Epilepsies, Partial complications, Epilepsy, Generalized physiopathology, Epilepsy, Generalized diagnosis, Epilepsy, Generalized complications
- Abstract
Epilepsy with eyelid myoclonia (EM) or Jeavons syndrome (JS) is an epileptic syndrome related to the spectrum of genetic generalized epilepsies (GGE). We report two untreated children on which EEGs were performed several hours after a generalized tonic-clonic seizure (GTCS). These showed a unilateral, nearly continuous posterior slowing. This slow-wave activity was associated with contralateral epileptiform activity in one case, while in the second case, it was associated with an ipsilateral activity. However, in the latter child, a few months later an independent focus on the contralateral side was observed. A diagnosis of focal occipital lobe epilepsy was proposed in both cases, and one child underwent a left occipital lobectomy at 3.5 years of age. Despite surgery, absences with EM persisted in this child, and a marked photosensitivity to photic stimulation was observed two years later. The focal slow wave activity of one occipital lobe several hours after a GTCS in these two subjects was in favor of a focal onset preceding the generalization. The EEG evidence for independent left and right posterior focus in these two cases, the persistence of EM, and the development of a marked photosensitivity to photic stimulation in the child who underwent an occipital lobectomy, allow us to suggest that JS is associated with a network of bi-occipital hyperexcitability that rapidly engages bilaterally to produce generalized seizures., Competing Interests: Declaration of competing interest Dr. Gelisse received support for teaching programs from Sanofi, UCB, EISAI and Psicofarma. He received a research grant from Janssen-Cilag. He worked as a consultant for Eisai-France in 2011. Dr. Crespel received support for teaching programs from Sanofi, UCB, GSK, Shire and is an advisory board member for Eisai-France. Dr. Genton received speaker invitations and honoraria from Sanofi-Aventis, Novartis, GSK, Pfizer, Janssen-Cilag, UCB, Eisai, and Actelion. He received support for teaching programs from Sanofi-Aventis and UCB. Dr Nilo received support as a consultant from Eisai-Italy. Dr. Gallegos, Dr Macorig report no conflicts of interest. All co-authors have been substantially involved in the study and preparation of the manuscript. No undisclosed persons have had a primary role in the study or manuscript preparation. All co-authors have approved the submitted version of the paper and accept responsibility for its content., (Copyright © 2024 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF